Transgenex Nanobiotech, Inc.

TransGenex Nanobiotech, Inc. (TGN) is a Florida-based nanobiotechnology company incorporated in 2004.

Our Mission is "To discover, develop and commercialize nano-scale technologies and platforms for novel and cost-effective diagnostic and therapeutic agents against cancers and other inflammatory diseases."

Contact Us

Fiss (TM)

Aiding the effort in anti-cancer drug discovery and development.


Sign up for our newsletter and stay up-to-date with new developments & more from TGN.